HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

NORMACOL PLUS overview
The treatment of constipation, particularly hypertonic or slow transit constipation, resistant to bulk alone. The initiation and maintenance of bowel action after rectal surgery and after haemorrhoidectomy.
banner_pass = 1

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
NORMACOL PLUS
Drug Class Description :

Bulking agents.

Generic Name :

Sterculia, frangula

Drug description :

The active ingredients are 62% Sterculia and 8.0% Frangula.

Presentation :

Brown granules.

Indications :

The treatment of constipation, particularly hypertonic or slow transit constipation, resistant to bulk alone. The initiation and maintenance of bowel action after rectal surgery and after haemorrhoidectomy.

Adult Dosage :

Adults (including the elderly): 1 or 2 sachets or 1-2 heaped 5ml spoonfuls, once or twice daily after meals.

The granules should be placed on the tongue and, without chewing or crushing, swallowed immediately with plenty of water or a cool drink. Prior to drinking they may also be sprinkled on and taken with soft food such as yoghurt

Child Dosage :

Children (6 – 12 years): A reduced amount may be given at the discretion of the physician.

Contra Indications :

Intestinal obstruction, faecal impaction and total atony of the colon.

Known hypersensitivity to the ingredients

Special Precautions :

Caution should be exercised in the use of NORMACOL Plus in cases of ulcerative colitis. Patients should be advised to maintain an adequate fluid intake, to avoid NORMACOL Plus immediately before going to bed or in a recumbent position (especially if they are elderly) and to suspend treatment if bowel movements do not occur within four days.

Prolonged and excessive use of stimulant laxatives can cause dependence and loss of normal bowel function

Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

Adverse Reactions :

Immune system disorders: allergic reactions

Gastrointestinal disorders:

Intestinal/colonic obstruction or impaction, abdominal cramp

Oesophageal obstruction is possible if the product is not adequately washed down with fluid.

Abdominal distension may occur.

Manufacturer :

Norgine

Drug Availability :

GSL

Drug Updated :

02 June 2009

Related Drugs - Laxatives
Advancing Immunotherapy in Oncology Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Chronic Kidney Disease (CKD) is characterised by a gradual and permanent loss of kidney function that worsens as it progresses from stages 1 to 5. One of the most common complications of CKD is anaemia. Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age.
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES